Lakewood Capital Still Shorting Pot Stocks, Korean Biotech

The end of 2018 brought a return to reality in the form of a steep bear market for equities. Of course, it created a nearly impossible situation for many funds on the long side, but it was actually good news for some short-sellers. Lakewood Capital was one of those which managed to capitalize on the tumbling stock market through several key short positions.

Q4 hedge fund letters, conference, scoops etc

Lakewood Capital sees strong returns on shorts
Reputable short-seller Anthony Bozza said in his annual letter for the fund that their short positions generated a return of 34% for the fourth quarter. However, the strong results from their short portfolio toward the end of the year have them treading lightly now.

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible


Saved Articles
X
TextTExtLInkTextTExtLInk

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required


Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up today and get three months free

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 10/31/2019 or after next 25 20 subscribers take advantage whichever comes first – please do not share this discount with others

 

0